Bibliography
- Rennie KL , JebbSA. Prevalence of obesity in Great Britain.Obes. Rev.6, 11–12 (2005).
- Baskin ML , ArdJ, FranklinF, AllisonDB. Prevalence of obesity in the United States.Obes. Rev.6, 5–7 (2005).
- Trayhurn P , WoodIS. Adipokines: inflammation and the pleiotropic role of white adipose tissue.Br. J. Nutr.92, 347–355 (2004).
- Ahima RS , FlierJS. Leptin.Annu. Rev. Physiol.62, 413–437 (2000)
- Zhang Y , ProencaR, MaffeiM, BaroneM, LeopoldL, FriedmanJM. Positional cloning of the mouse obese gene and its human homologue.Nature372, 425–432 (1994).
- Berg AH , SchererPE. Adipose tissue, inflammation and cardiovascular disease.Circ. Res.96, 939–949 (2005).
- Waki H , YamauchiT, KamonJ. Impaired multimerization of human adiponectin mutants associated with diabetes: molecular structure and multimer formation of adiponectin.J. Biol. Chem.278, 40352–40363 (2003)
- Kadowaki T , YamauchiT. Adiponectin and adiponectin receptors.Endocrin. Rev.26, 439–451(2005)
- Steppan CM , BaileyST, BhatS. The hormone resistin links obesity to diabetes.Nature409, 307–312 (2001).
- Kim KH , LeeK, MoonYS, SulHK. A cysteine-rich adipose tissue specific secretory factor inhibits adipocyte differentiation.J. Biol. Chem.276, 11252–11256 (2001).
- Todorov PT , McDevittTM, MeyerDJ, UeyamaH, OhkuboI, TisdaleMJ. Purification and characterization of a tumour-lipid mobilizing factor.Cancer Res.58, 2353–2358 (1998).
- Bing C , BaoY, JenkinsJ. Zinc-α2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.Proc. Natl Acad. Sci.101, 2500–2505 (2004).
- Russell ST , ZimmermanTP, DominBA, TisdaleMJ. Induction of lipolysis in vitro and loss of body fat in vivo by Zinc-α2-glycoprotein. Biochim. Biphys. Acta.1636, 59–68 (2004).
- Russell ST , TisdaleMJ. Antidiabetic properties of Zinc-α2-glycoprotein in ob/ob mice.Endocrinol151, 948–957 (2010).
- Mracek T , StephensN, GaoDet al. Zinc-α2-glycoprotein in adipose atrophy in human cancer cachexia. Presented at: The 5th Cachexia Conference. Barcelona, Spain, 5–8 December (2009).
- Mracek T , DingQ, TzanavariTet al. The adipokine Zinc-α2-glycoprotein is downregulated with fat mass expansion in obesity. Clin. Endocrinol. 72, 334–341 (2010).
- Gong F -Y, Zhang S-J, Ding J-Y et al. Zinc-α2-glycoprotein is involved in regulation of body weight through inhibition of lipogenic enzymes in adipose tissue. Int. J. Obese.33, 1023–1030 (2009).
- Rolli V , RadosavljevicM, AstierVet al. Lipolysis is altered in MHC Class I Zinc-α2-glycoprotein deficient mice. FEBS Lett. 581, 394–400 (2007).
- Vettor R , PaganoC. The role of the endocannabinoid system in lipogenesis and fatty acid metabolism.Best Pract. Res. Clin. Endocrinol. Metab.23, 52–63 (2009).
- Després JP , Van Gaal L, Pi-Sunyer X, Scheen A. Efficacy and safety of the weight-loss drug rimonabant. Lancet.371(9612), 555 (2008).
- Trayhurn P , WoodIS. Signalling role of adipose tissue: adipokines and inflammation in obesity.Biochem. Soc. Trans.33, 1078–1081 (2005).
- van Dielen FMH , BuurmanWA, HadfouneM, NijhuisJ, GreveJ. Macrophage inhibitory factor, plasminogen activator inhibitor-1, other acute phase proteins and inflammatory mediators normalize as a result of weight loss in morbidly obese subjects treated with gastric restrictive surgery.J. Clin. Endo. Met.89(8) 4062–4068 (2004)
- de Luca C , OlefskyJM. Inflammation and insulin resistance.FEBS Lett.582(1), 97–105 (2008).